home / stock / clsn / clsn news

CLSN News and Press, Celsion Corporation From 11/15/21

Stock Information
Company Name: Celsion Corporation
Stock Symbol: CLSN
Market: NASDAQ
Website: celsion.com
Menu
CLSN CLSN Quote CLSN Short CLSN News CLSN Articles CLSN Message Board
Get CLSN Alerts

News, Short Squeeze, Breakout and More Instantly...
CLSN - Celsion Corporation Reports Third Quarter 2021 Financial Results and Provides Business Update

Balance Sheet Supports Focus o n Immuno-Oncology and Next-Generation Vaccine Initiative Conference Call Begins Today at 11:00 a.m. Eastern Time LAWRENCEVILLE, N.J., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation ...
CLSN - Notable earnings before Monday's open

ACM, ACRX, ADN, AMPY, AVPT, AYRO, BCLI, BFLY, CLSN, OTCQB:CVSI, FREY, GMDA, GOED, KALA, MICT, OEG, ONDS, OTLY, PLX, PTN, RAIL, SOHU, TLS, TRVN, TSN, VBLT For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings before Monday's open

CLSN - Celsion Corporation to Hold Third Quarter 2021 Financial Results and Business Update Conference Call on Monday, November 15, 2021

LAWRENCEVILLE, N.J., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) , a clinical-stage development company focused on DNA-based immunotherapy and next-generation vaccines, announced today that the Company will host a conference call at 11:00 a.m. E...

CLSN - Celsion Provides Update on its Application to Sell $1.5 Million of New Jersey Net Operating Losses

Application A pproval Will Further Extend Current Operating Runway to Over Three Years To date, through the New Jersey Technology Business Tax Certificate Transfer (NOL) Program , Celsion has r aised over $14 mi...
CLSN - Celsion Corporation's GEN-1 IL-12 Program to be Featured at Cytokine-Based Cancer Immunotherapies Summit

Chief Science Officer Dr. Khursheed Anwer to also Participate in Two Panel Discussions LAWRENCEVILLE, N.J., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company focused on DNA-based immunotherapy and next-...

CLSN - Celsion Corporation Announces Time of Oral Presentation at International Vaccines Congress

Chief Science Officer Dr. Khursheed Anwer to D eliver V irtual P resentation Monday, October 18 at 7:30 a.m. Eastern Time LAWRENCEVILLE, N.J., Oct. 15, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage development c...

CLSN - Celsion Corporation Announces Oral Presentation at International Vaccines Congress

Chief Science Officer Dr. Khursheed Anwer to D eliver V irtual P resentation on Celsion’s O ngoing W ork with DNA-based V accines LAWRENCEVILLE, N.J., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), ...
CLSN - Celsion GmbH Announces the Publication of an Article Reviewing the History of ThermoDox® Drug Development in Advanced Drug Delivery Reviews

Investigator-Sponsored Research with ThermoDox ® Continues in Multiple Indications New Support for ThermoDox ® ’s P otential from the National Institutes of Health under a Cooperative Research and Dev...

CLSN - Celsion Corporation Adds Key Resources to its Vaccine Development Initiative and Clinical Trial Capabilities

LAWRENCEVILLE, N.J., Oct. 05, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) , a clinical-stage development company focused on DNA-based immunotherapy and next-generation vaccines, announces the strengthening of its management team with a new hire and a promotio...

CLSN - Celsion to Present at Three Investment Conferences in October

LAWRENCEVILLE, N.J., Sept. 30, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage company focused on DNA-based immunotherapy and next-generation vaccines, today announced that management will present at the following investment conferences in October: ...
Previous 10 Next 10